Fig. 1.

Summary of the final disposition of patients in the VERNACULAR Study. Two hundred thirty-one patients were enrolled, and 170 were treated with the Venovo venous stent. One hundred twenty-eight patients completed the study while 42 patients either withdrew consent or were withdrawn by an investigator (14), were lost to follow-up (19), died (6), or discontinued participation for other reasons (3). Due to the COVID-19 pandemic, the final 36-month follow-up window was extended beyond 1125 days to allow patients to complete the study